Scholarly Index
Zhijie Xu
Central South University; 6,702 total citations; 227 total publications; best world rank #28
Central South University
6,702Total citations
227Total publications
47H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ferroptosis and cancer prognosis | Lifetime | 141 | CN 59 | 98.00 |
| Extracellular vesicles in disease | Lifetime | 677 | CN 224 | 95.25 |
| Epigenetics and DNA Methylation | 2021-2025 | 28 | CN 11 | 98.86 |
| RNA modifications and cancer | 2021-2025 | 55 | CN 37 | 99.32 |
| Ferroptosis and cancer prognosis | 2021-2025 | 36 | CN 26 | 99.32 |
| MicroRNA in disease regulation | 2021-2025 | 65 | CN 41 | 98.88 |
| Cancer-related molecular mechanisms research | 2021-2025 | 134 | CN 101 | 98.64 |
| Immune cells in cancer | 2021-2025 | 115 | CN 69 | 97.24 |
| Extracellular vesicles in disease | 2021-2025 | 147 | CN 92 | 97.06 |
| Circular RNAs in diseases | 2021-2025 | 237 | CN 172 | 94.86 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 348 | CN 147 | 92.49 |
| Cancer-related gene regulation | 2021-2025 | 183 | CN 122 | 91.69 |
| Inflammasome and immune disorders | 2021-2025 | 248 | CN 122 | 91.86 |
| Renal cell carcinoma treatment | 2021-2025 | 459 | CN 49 | 93.36 |
| Autophagy in Disease and Therapy | 2021-2025 | 977 | CN 480 | 81.58 |
| interferon and immune responses | 2021-2025 | 967 | CN 535 | 80.23 |
| Fibroblast Growth Factor Research | 2021-2025 | 349 | CN 104 | 74.24 |